PAZOPANIB for Renal cancer metastatic: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 366 adverse event reports in the FDA FAERS database where PAZOPANIB was used for Renal cancer metastatic.

Most Reported Side Effects for PAZOPANIB

Side Effect	Reports	%	Deaths	Hosp.
Death	3,767	17.8%	3,764	211
Diarrhoea	2,907	13.7%	213	501
Fatigue	1,883	8.9%	173	315
Nausea	1,879	8.9%	192	413
Malignant neoplasm progression	1,471	6.9%	570	372
Drug ineffective	1,135	5.4%	160	141
Decreased appetite	1,116	5.3%	196	321
Vomiting	1,072	5.1%	153	366
Hypertension	1,004	4.7%	104	271
Malaise	764	3.6%	148	254
Disease progression	739	3.5%	185	82
Asthenia	727	3.4%	161	280
Product use in unapproved indication	724	3.4%	153	60
Weight decreased	697	3.3%	85	168
Hair colour changes	679	3.2%	41	83